Utilization of ¹²⁵I monoclonal antibody in the management of primary glioblastoma multiforme

This publication has 18 references indexed in Scilit:

• Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: A phase II trial
  International Journal of Radiation Oncology*Biology*Physics, 1992
• Cell cycle dependence of epidermal growth factor induced radiosensitization
  International Journal of Radiation Oncology*Biology*Physics, 1992
• Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme
  Journal of Neurosurgery, 1992
• Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptide
  Archives of Biochemistry and Biophysics, 1987
• Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess
  Journal of Immunological Methods, 1984
• Radioactive Labeling of Antibody: A Simple and Efficient Method
  Science, 1983
• Iodine-125 cytotoxicity: Implications for therapy and estimation of radiation risk
  International Journal of Nuclear Medicine and Biology, 1981
• Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril
  Biochemical and Biophysical Research Communications, 1978
• The Radiotoxicity of Iodine-125 in Mammalian Cells: II. A Comparative Study on Cell Survival and Cytogenetic Responses to 125 IUdR, 131 IUdR, and 3 HTdR
  Radiation Research, 1976